Fifth Joint European Societies Taskforce. Update to the European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Eur Heart J2012; doi: 10.1093/eurheartj/ehs092 (in press).
2.
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J2011; 32: 1769–1818.
3.
RidkerPMDanielsonEFonsecaFAH. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med2008; 359: 2195–2207.
MuntendamPMcCallCSanzJ. The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease – study design and objectives. Am Heart J2010; 160: 49–57.
